Home
Tag
Indian Pharma Market
1 article
Results
RPG Life Sciences Q4 Revenue Up 23.6%
RPG Life Sciences reported Q4 FY26 revenue growth of 23.6% YoY to ₹176.9 crores with EBITDA margin of 25.6%. Domestic Formulations grew 18.2%, outperforming Indian Pharma Market growth of 10.1% in Q4.